VP Biology

Cambridge, UK


Dunad Therapeutics is a dynamic biopharmaceutical company focused on the development of next-generation targeted protein degradation therapies. Dunad’s platform enables selective degradation via direct target modification using tuneable mono-valent small molecules, allowing for the development of more drug-like, orally bioavailable,

and CNS-accessible protein degraders.